SCHEMBL1968036

SCHEMBL1968036

O=C(Nc1nc(C(F)(F)F)cs1)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.62
RAB9A P51151 4/20 0.62
KDM4A O75164 2/20 0.57
KDM4B O94953 2/20 0.57
KDM5B Q9UGL1 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
ADORA3 P0DMS8 2/20 0.57
TAS1R3 Q7RTX0 1/20 0.57
TAS1R1 Q7RTX1 1/20 0.57
TAS1R2 Q8TE23 1/20 0.57
SCD O00767 1/20 0.56
MAPT P10636 3/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
KDM4E B2RXH2 2/20 0.54
PDE5A O76074 1/20 0.54
ALDH1A1 P00352 1/20 0.54
PKM P14618 1/20 0.54
ALOX15 P16050 1/20 0.54
TSHR P16473 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27845355 0.90 NPC1 (0.52) NPC1RAB9AKDM4AKDM4BKDM5B
SCHEMBL77592 0.85 SMN1; SMN2 (0.77) NPC1RAB9AKDM4AKDM4BKDM5B
SCHEMBL8890163 0.85 GRM5 (0.58) NPC1RAB9ASMN1; SMN2TAS1R3TAS1R1
SCHEMBL741587 0.82 NPC1 (0.76) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL3610148 0.81 FFAR2 (0.51) NPC1RAB9ASMN1; SMN2TAS1R3TAS1R1
SCHEMBL13055749 0.80 RAB9A (0.57) NPC1RAB9ASMN1; SMN2ADORA3TAS1R3
SCHEMBL3791723 0.80 KMT2A (0.53) NPC1RAB9ASMN1; SMN2MAPTMEN1
SCHEMBL16318533 0.80 GCK (0.52) NPC1RAB9ASMN1; SMN2TAS1R3TAS1R1
SCHEMBL16321719 0.78 ALOX15 (0.49) NPC1RAB9ASMN1; SMN2TAS1R3TAS1R1
SCHEMBL13055750 0.78 NPC1 (0.52) NPC1RAB9ASMN1; SMN2TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334652-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS Boehringer Ingelheim International GmbH (DE) 2011-06-22 EP disclosed